Sheahan, Anna
Anjohrin, Suzanne
Suruki, Robert
Stark, Jeffrey L. http://orcid.org/0000-0001-7716-2727
Sloan, Victor S.
Funding for this research was provided by:
UCB Pharma
Article History
Received: 27 November 2023
Revised: 20 February 2024
Accepted: 17 March 2024
First Online: 25 April 2024
Declarations
:
: Patient data were de-identified; thus, the use of the data does not constitute human subject research and does not require approval from an institutional review board.
: IBM<sup>®</sup> MarketScan<sup>®</sup> is Health Insurance Portability and Accountability Act (HIPAA) compliant. Patient data were de-identified; thus, the use of the data does not constitute human subject research and does not require approval from an institutional review board. Analyses were performed with permission of the data owner to be presented at an aggregate level.
: AS: Former employee of UCB Pharma; shareholder of UCB Pharma. SA, JLS: Employees and shareholders of UCB Pharma. RS: Employee of Janssen; former employee of UCB Pharma; shareholder of GSK and UCB Pharma. VSS: Former employee of, consultant to, and shareholder of UCB Pharma; faculty of Rutgers Robert Wood Johnson Medical School; employee of the Peace Corps. This work was prepared by Victor Sloan in his personal capacity. The opinions expressed are not necessarily those of the Peace Corps or the United States government.